These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36254251)

  • 1. Integrated analyses of brain and platelet omics reveal their common altered and driven molecules in Alzheimer's disease.
    Yu H; Li M; Pan Q; Liu Y; Zhang Y; He T; Yang H; Xiao Y; Weng Y; Gao Y; Ke D; Chai G; Wang JZ
    MedComm (2020); 2022 Dec; 3(4):e180. PubMed ID: 36254251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet biomarkers for a descending cognitive function: A proteomic approach.
    Yu H; Liu Y; He B; He T; Chen C; He J; Yang X; Wang JZ
    Aging Cell; 2021 May; 20(5):e13358. PubMed ID: 33942972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-Derived Amyloid-β Protein Precursor as a Biomarker of Alzheimer's Disease.
    Wang Q; Shi Y; Qi X; Qi L; Chen X; Shi J; Xie C; Zhang Z
    J Alzheimers Dis; 2022; 88(2):589-599. PubMed ID: 35662121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer's disease.
    Clark C; Rabl M; Dayon L; Popp J
    Front Aging Neurosci; 2022; 14():1065904. PubMed ID: 36570537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating peripheral blood and brain transcriptomics to identify immunological features associated with Alzheimer's disease in mild cognitive impairment patients.
    Qian XH; Liu XL; Chen SD; Tang HD
    Front Immunol; 2022; 13():986346. PubMed ID: 36159817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease.
    Donovan LE; Dammer EB; Duong DM; Hanfelt JJ; Levey AI; Seyfried NT; Lah JJ
    Alzheimers Res Ther; 2013; 5(3):32. PubMed ID: 23764030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased apoptosis in the platelets of patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Zhao S; Zhao J; Zhang T; Guo C
    Clin Neurol Neurosurg; 2016 Apr; 143():46-50. PubMed ID: 26895209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets and Alzheimer's disease: Potential of APP as a biomarker.
    Evin G; Li QX
    World J Psychiatry; 2012 Dec; 2(6):102-13. PubMed ID: 24175176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet Proteomic Analysis Revealed Differential Pattern of Cytoskeletal- and Immune-Related Proteins at Early Stages of Alzheimer's Disease.
    González-Sánchez M; Díaz T; Pascual C; Antequera D; Herrero-San Martín A; Llamas-Velasco S; Villarejo-Galende A; Bartolome F; Carro E
    Mol Neurobiol; 2018 Dec; 55(12):8815-8825. PubMed ID: 29603091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Analysis of Cortex Single-Cell Transcriptome and Serum Proteome Reveals the Novel Biomarkers in Alzheimer's Disease.
    Yu QS; Feng WQ; Shi LL; Niu RZ; Liu J
    Brain Sci; 2022 Aug; 12(8):. PubMed ID: 36009085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Amyloid promotes platelet activation and activated platelets act as bridge between risk factors and Alzheimer's disease.
    Li TR; Liu FQ
    Mech Ageing Dev; 2022 Oct; 207():111725. PubMed ID: 35995275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet Tau Protein as a Potential Peripheral Biomarker in Alzheimer's Disease: An Explorative Study.
    Mukaetova-Ladinska EB; Abdell-All Z; Andrade J; da Silva JA; Boksha I; Burbaeva G; Kalaria RN; T O Brien J
    Curr Alzheimer Res; 2018; 15(9):800-808. PubMed ID: 29623842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review on omics-based biomarkers discovery for Alzheimer's disease from the bioinformatics perspectives: Statistical approach vs machine learning approach.
    Tan MS; Cheah PL; Chin AV; Looi LM; Chang SW
    Comput Biol Med; 2021 Dec; 139():104947. PubMed ID: 34678481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-omics analyses highlight molecular differences between clinical and neuropathological diagnoses in Alzheimer's disease.
    Lüleci HB; Jones A; Çakır T
    Eur J Neurosci; 2024 Sep; 60(5):4922-4936. PubMed ID: 39072881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet TAU is Associated with Changes in Depression and Alzheimer's Disease.
    Sarg B; Korde DS; Marksteiner J; Humpel C
    Front Biosci (Landmark Ed); 2022 May; 27(5):153. PubMed ID: 35638420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.